Progesterone inhibits arterial smooth muscle cell proliferation.

Published in: Nat Med
By: Lee WS, Harder JA, Yoshizumi M, Lee ME, Haber E.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 420. November 2008: hormone therapy and heart disease.

Published in: Obstet Gynecol.
By:

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

Published in: Int J Cancer.
By: Bakken K, Alsaker E, Eggen AE, Lund E.

Breast-cancer risk following long-term oestrogen- and oestrogenprogestin- replacement therapy.

Published in: Int J Cancer.
By: Magnusson C, Baron JA, Correia N, Bergström R, Adami HO, Persson I.

First pregnancy characteristics and subsequent breast cancer risk among young women

Published in: Int J Cancer.
By: Innes KE, Byers TE.

Pregnancy characteristics and maternal risk of breast cancer.

Published in: Epidemiology
By: Troisi R, Weiss HA, Hoover RN, et al.

Pre-eclampsia in pregnancy and subsequent risk for breast cancer.

Published in: Br J Cancer
By: Vatten LJ, Romundstad PR, Trichopoulos D, Skjærven R.

Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features.

Published in: Am J Clin Pathol
By: Veronese SM, Gambacorta M.

Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women.

Published in: Am J Obstet Gynecol
By: Jensen J, Riis BJ, Strøm V, Nilas L, Christiansen C.

Effects of hormone replacement on therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys.

Published in: J Am Coll Cardiol
By: Williams JK, Honoré EK, Washburn SA, Clarkson TB.

Pages